Purchase Order 75N91020P00055
Award Date 11/26/19
Potential Completion Date 1/31/20
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $16,000 on June 25, 2018, with final completion on June 24, 2019. The order is firm fixed price with no set-aside. Work is performed in Morrisville, North Carolina. Metabolon, a self-certified small disadvantaged business, provides metabolomics analysis services, including metabolite identification and quantification using ultra-high performance liquid chromatography and tandem mass spectrometry across biological...
- The National Cancer Institute awarded a $16,000 purchase order to Metabolon, Inc. for custom metabolomics services on July 25, 2017, with completion on July 25, 2018. Work is performed in Durham, North Carolina. The order is firm fixed price with no set-aside designation. Metabolon is a self-certified small disadvantaged business specializing in metabolomic profiling and analysis using advanced chromatography and mass spectrometry techniques across biological sample types including plasma,...
- The National Cancer Institute awarded a purchase order to Metabolon, Inc. for laboratory testing services on July 27, 2017, with a ceiling value of $15,500.00 and a completion date of July 31, 2018. Work is performed in Durham, North Carolina. Metabolon is a self-certified small disadvantaged business providing metabolomic analysis and profiling services using advanced analytical techniques including ultra-high performance liquid chromatography and tandem mass spectrometry. The purchase order...
- The National Cancer Institute awarded a $12,000 firm fixed-price purchase order to Metabolon, Inc. on June 8, 2018, with final completion on June 7, 2019. Performance is at Metabolon's facility in Morrisville, North Carolina. The order procures metabolomic analysis services, including identification and quantification of metabolites from biological samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small disadvantaged business.
- The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $19,200.00 on August 1, 2018, with final completion on August 18, 2018. No set-aside was used. Work is performed in Morrisville, North Carolina. The order covers metabolomic analysis services, including identification and quantification of metabolites from biological samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small disadvantaged business.
- <p>The National Cancer Institute awarded a purchase order to Metabolon, Inc. valued at $14,400.00 on September 15, 2017. No set-aside was used. The order is firm fixed price and runs through November 1, 2017. Work is performed in Morrisville, North Carolina. Metabolon is a self-certified small disadvantaged business providing metabolomics services, including metabolomic profiling of biological samples using advanced analytical techniques to support federal research initiatives.</p>
- The National Cancer Institute awarded a purchase order to Metabolon, Inc. for $14,200 on May 24, 2019, with completion by August 1, 2019. The order is firm fixed price with no set-aside designation. Metabolon will deliver a relative concentration profile of small-molecule entities (endogenous compounds, xenobiotics, and metabolites) extracted from 40 cell pellets and detected via the HD4 global metabolomics platform, provided as an Excel file. The awardee will supply an outline of analytical...
- The National Cancer Institute awarded a purchase order to Metabolon, Inc. valued at $24,900 for metabolomics analysis of pancreatic cancer samples, with an award date of August 16, 2019 and completion by October 31, 2019. Performance occurs in Morrisville, North Carolina. The order calls for advanced scientific analysis and research support through specialized metabolomic testing using ultra-high performance liquid chromatography and tandem mass spectrometry to enable comprehensive metabolic...
- The National Cancer Institute awarded a purchase order to Metabolon, Inc. valued at $177,500 for metabolomic research and serum sample analysis in pancreatic cancer, with an award date of September 16, 2016 and completion date of September 15, 2018. Work is performed at Metabolon's Rockville, Maryland facility. The order covers analysis and metabolic profiling of serum samples using ultra-high performance liquid chromatography and tandem mass spectrometry. Metabolon is a self-certified small...
- <p>The National Institutes of Health Clinical Center awarded a purchase order to Metabolon, Inc. for $16,000.00 on January 18, 2019, with completion on January 18, 2020. Work is performed in Morrisville, North Carolina. The order procures metabolomics services, including advanced scientific analysis and metabolite identification using ultra-high performance liquid chromatography and tandem mass spectrometry on biological samples. Metabolon is a self-certified small disadvantaged business.</p>
The National Cancer Institute awarded a $16,200 purchase order to Metabolon, Inc. for lab and testing services, effective November 26, 2019 with completion by January 31, 2020. Work is performed in Morrisville, North Carolina. No set-aside category applies. Metabolon, a self-certified small disadvantaged business, provides metabolomics services including metabolite identification and quantification using ultra-high performance liquid chromatography and tandem mass spectrometry for biological sample analysis across plasma, serum, tissue, stool, and urine matrices.
Generated 8/1/26, 10:48 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.2k | 11/25/19 |